This Newsletter covers Federal and State policy and legislative developments in the area of health. Copies of documents referred to can be obtained by clicking on the reference in this Newsletter or through Capital Monitor's collection at www.capitalmonitor.com.au or from the source quoted.
None this edition.
None this edition.
None this edition.
None this edition.
None this edition.
None this edition.
23 June
NSW budget commits to improving safer, more supportive care
The Pharmaceutical Society of Australia (PSA) welcomed the NSW Government's budget initiatives that will improve medicine safety and outcomes for patients across NSW. The 2021-22 NSW Budget commits $37.3 million to the implementation of Real Time Prescription Monitoring (RTPM), and $82.8 million over four years to bolster palliative care services across the state. PSA has long advocated for a nationally consistent RTPM system across the country in order to reduce inappropriate medicine use and the harm it may cause. PSA NSW President, Chelsea Felkai, welcomed this commitment.
Download
22 June
Australian Industrial Chemicals Introduction Scheme appointment
The Coalition Government has appointed Graeme Barden as the new Executive Director of the nation's industrial chemicals assessment and regulatory body, the Australian Industrial Chemicals Introduction Scheme (AICIS). Minister for Regional Health Mark Coulton said he was pleased that AICIS will be in the capable and experienced hands of Mr Barden for the next five years. Mr Barden distinguished himself during the COVID-19 pandemic, serving as First Assistant Secretary in the Office of Health Protection and Response in the Department of Health. Minister Coulton said Mr Barden's appointment follows the retirement of the inaugural Executive Director, Dr Brian Richards.
Download
Australia-Canada-Singapore-Switzerland-United Kingdom (Access) Consortium
The Department of Health, Therapeutic Goods Administration (TGA) said that the trend towards globalisation of therapeutic product industries and the rapid emergence of new technologies have created an increased need for regulatory bodies to communicate with each other routinely. This maximises the use of up-to-date technical expertise, and ensures a consistent, contemporary approach to assessing the benefits and risks associated with the use of therapeutic products. The Access Consortium Strategic Plan 2021-2024 (//www.tga.gov.au/resource/access-consortiumstrategic- plan-2021-2024) was endorsed by the five regulatory authorities and published in June 2021. The consortium's goal is to maximise international cooperation, reduce duplication, and increase each agency's capacity to ensure consumers have timely access to high quality, safe and effective therapeutic products.
Download
Correction of chemical names
The Department of Health and National Industrial Chemicals Notification and Assessment Scheme (NICNAS) updated the names of the following chemicals in the Australian Inventory of Industrial Chemicals (AIIC) to the Chemical Abstracts Service (CAS) name. These corrections do not change the identity of the chemical substances themselves.
Download
Return to top
Research
24 June
Suicide Prevention Research Grants to Improve Crisis Response
Minister for Health Greg Hunt and Assistant Minister to the Prime Minister for Mental Health and Suicide Prevention David Coleman said that the Government is investing $2.53 million in two research projects to improve support for Australians experiencing emotional distress or a suicidal crisis. Suicide prevention is a key priority for the Morrison Government. In 2019, 3,318 Australians lost their lives to suicide. Each death is a national tragedy and has a devastating effect on friends, families and communities. The Suicide Prevention Research Fund supports research into suicide prevention and is managed by Suicide Prevention Australia, the national peak body for the suicide prevention sector.
Download
23 June
ACU research leads to a new standard dose in cannabis research in the US
The work of Australian Catholic University (ACU) neuroscientist Valentina Lorenzetti has led the top US federal health agency to announce a new standard dose of delta-9-tetrahydrocannabinol (THC) - the main chemical responsible for the psychotropic and addictive properties of cannabis. The standard dose will be used by researchers to enable more accurate and useful research into the effects of cannabis use. The National Institute on Drug Abuse (NIDA) has advised researchers of the new requirement to measure and report results using a standard THC unit of five milligrams in all human subjects' research.
Download
22 June
VIC: Superbugs arrested by Victoria's genetic super-sleuths
The Victorian Government's investment in a world-first genomics sequencing trial is stopping hospital superbugs in their tracks - preventing outbreaks and saving lives. The $35 million in funding for the Melbourne Genomics Health Alliance announced last November is already producing better patient care for Victorians and promising continuing advancements in patient diagnosis and treatment. Melbourne Genomics' expertise has also played a crucial role in tracking the transmission of coronavirus in Victoria. In hospitals, scientists and doctors are winning the war against potentially fatal outbreaks of superbugs - antibiotic-resistant bacteria - through Melbourne Genomics' Controlling Superbugs clinical project, said Victorian Acting Premier James Merlino and Victorian Minister for Innovation, Medical Research and the Digital Economy Jaala Pulford.
Download
21 June
Non-alcoholic fatty liver disease found in over one-third of rural Victorians
The prevalence of non-alcoholic fatty liver disease - a major cause of cirrhosis and liver cancer - may be as high as 45% in rural Victoria, according to research published in the Medical Journal of Australia (MJA). Researchers led by Professor Stuart Roberts, Director of Hepatology at Alfred Health in Melbourne, analysed data from 705 invited adults from four towns in the Goulburn Valley of Victoria. Participants completed clinical, laboratory and questionnaire evaluations of alcohol use. Of the 705 participants, 274 met the fatty liver index criterion for NAFLD (crude prevalence, 38.9%; age- and sex standardised prevalence, 35.7%).
Download
Type 1 Diabetes: Need for equitable access to technology for patients
All people with type 1 diabetes should have equitable access to the most effective management systems, including technology where clinically appropriate, regardless of age, concessional status or level of private health insurance cover, according to the authors of a consensus statement published by the MJA. A working group comprising of representatives from the Australian Diabetes Society (ADS), the Australian Diabetes Educators Association (ADEA), the Australasian Paediatric Endocrine Group (APEG) and the Australasian Diabetes in Pregnancy Society (ADIPS) produced the consensus statement to be read in conjunction with the Australian living evidence guidelines in diabetes.
Download
20 June
$74 million investment in Australian-led clinical trials
A study involving 15,000 Australians which aims to develop a next-generation, standardised diagnosis for melanoma is one of 30 clinical trials and cohort studies to be funded through the Government's $74 million investment to find better ways to prevent, detect and treat disease. The $3.2 million melanoma cohort study will be the first in the world to document on such a large scale the whole skin surface of participants with histopathology images and other patient details. Minister Hunt said the trial would help to discover more effective diagnosis options thousands of Australians who are tested for skin cancer each year.
Download
Return to top
Rural, Regional and Remote Health
24 June
Boost to rural health training
The Australian Government will extend one of the nation's premier rural health workforce initiatives, following an evaluation of the programme highlighted its effectiveness in addressing workforce shortages. Minister for Regional Health Mark Coulton said Rural Health Multidisciplinary Training Program will continue to provide more than $200 million per year over three years to fund a network of rural clinical schools, university departments of rural health, and regional training hubs across rural and remote Australia. The reforms, to be phased in from 1 January 2022, will focus on key program outcomes such as student selection and quality placements, strengthening research networks, and responding to community and workforce need.
Download
Update on Norfolk Island health services
'I am pleased to confirm that the New South Wales Government has agreed to a final extension of its delivery of health services on Norfolk Island to the end of 2021,' said Assistant Minister for Regional Development and Territories Nola Marino. 'I thank the NSW Government for the six-month extension which will allow time for a managed and staged transition of health service delivery arrangements under the new, enduring partnership with the Queensland Government. This also aligns NSW's health service provision with the previously announced extension of education services on Norfolk Island to the end of 2021.'
Download
Return to top
Women's Health
18 June
Greens renew call for publicly funded abortion after private clinic closures
The Greens have renewed their call for publicly funded abortions after private service Marie Stopes announced it was shutting down four regional clinics in Queensland and New South Wales. Greens deputy leader and spokesperson on women Senator Larissa Waters said: 'The news that Marie Stopes is shutting down four regional clinics in Queensland and New South Wales is a massive blow for women's reproductive health. Access to sexual and reproductive health services such as long-acting contraception, medical and surgical abortions and counselling is already difficult in remote and regional areas, with many women forced to travel long distances, at significant expense, to get care.'
Download
Return to top
Transcripts
Minister for Home Affairs Karen Andrews
25 JUN: Transcript of Interview with Alison Langdon and Karl Stefanovic, Today Show, Channel Nine
Subjects: Victorian Government, Terrorism related offences, Courts, Crime, COVID-19, Public health, AFP, National security
Shadow Minister for Industry and Innovation Ed Husic
25 JUN: Transcript of Interview with Peter Stefanovic, Sky First Edition
Subjects: COVID-19, Pandemic, Sydney outbreak, Immunisation, Vaccine rollout, NSW Premier, Delta variant
Prime Minister Scott Morrison
24 JUN: Transcript of Interview with Karl Stefanovic & Allison Langdon, Today Show
Subjects: COVID-19, NSW, Quarantine, Lockdowns, Hotspots, Vaccinations, Pfizer, AstraZeneca, New Zealand, G7
Prime Minister Scott Morrison
24 JUN: Transcript of Interview with Natalie Barr, Sunrise
Subjects: NSW COVID-19, Vaccinations, AstraZeneca, Aged care
Prime Minister Scott Morrison
24 JUN: Transcript of Interview with Neil Breen, 4BC
Subjects: G7, Deputy Prime Minister, QLD, Power, Net zero emissions, NSW, Quarantine, Tourism
Leader of the Opposition Anthony Albanese
24 JUN: Speech to the Great Hall, Parliament House, Canberra - 'Winning the race'
Subjects: Economic recovery, Renewable energy, Skills, Education, Pharmaceutical production, Income & earnings, Wage suppression
Deputy Leader of the Australian Labor Party Richard Marles
24 JUN: Transcript of Interview with Tom Connell, Sky News
Subjects: COVID-19 in NSW, Purpose built quarantine, COVID-19 vaccination rollout, Net Zero by 2050, Emissions reduction, Energy policy, Coalition divisions, AFL
Shadow Minister for Northern Australia Murray Watt
24 JUN: Transcript of Interview with Peter Stefanovic, Sky News
Subjects: COVID outbreaks, PM, Vaccine, Quarantine, Murray Darling Basin amendments
Shadow Minister for Industrial Relations Tony Burke
24 JUN: Transcript of Interview with Laura Jayes, Sky News
Subjects: NSW Budget, Sydney COVID-19 outbreak, Vaccine rollout, AstraZeneca health advice
Shadow Minister for Defence Industry Matt Keogh
24 JUN: Transcript of Interview with Jade MacMillan, ABC News Capital Hill
Subjects: Alcohol in Parliament, COVID-19 vaccine rollout, NSW COVID-19 outbreak
Shadow Assistant Minister for Financial Services Matt Thistlethwaite
24 JUN: Transcript of Doorstop Interview, Canberra
Subjects: NSW COVID-19 outbreak, Vaccine rollout, Quarantine
Shadow Assistant Minister for Treasury Andrew Leigh
24 JUN: Transcript of Interview with Virginia Trioli, ABC Radio
Subjects: JobKeeper, Economy, NDIS, Welfare, Centrelink
Shadow Assistant Minister for Western Australia Patrick Gorman
24 JUN: Transcript of Interview with Tom Connell, Sky News
Subjects: Net zero, Emissions reduction, Nuclear power, NSW outbreak, COVID-19 vaccine rollout
Labor Member for Solomon Luke Gosling
24 JUN: Transcript of Interview with Katie Woolf, Mix 104.9 360
Subjects: Deputy Prime Minister, Veterans' wellbeing centres, Quarantine, COVID-19, Wellbeing, Mental health
Minister for Women Tanya Plibersek
23 JUN: Transcript of Interview with Laura Jayes, Sky News
Subjects: Parenting, Child care policy, Women's issues, Affordability of child care, Climate change policy, Deputy PM, Vaccine rollout, Slovenian Independence
Shadow Treasurer Jim Chalmers
23 JUN: Transcript of Doorstop Interview, Parliament House, Canberra
Subjects: Wages, National leadership, Regional Queensland, Emissions reduction, Child care, COVID-19 vaccines, Quarantine
Labor Member for Canberra Alicia Payne
23 JUN: Transcript of Interview with Jane Norman, ABC Capital Hill
Subjects: Child care funding, Deputy PM, National Party leadership, Climate change policy, Agriculture, COVID-19 outbreak, Vaccine rollout
Australian Prudential Regulation Authority (APRA)
23 JUN: Speech by General Manager, Insurance Division, John Huijsen, to the Health Insurance Summit
Subjects: Recovery, Private health insurance, COVID-19
Leader of the Opposition Anthony Albanese
22 JUN: Transcript of Interview with Lisa Millar, ABC News Breakfast
Subjects: Member for New England, National Party, COVID-19, Public health, Vaccine rollout, Hotel quarantine, PM, Climate change, Net zero by 2050, Great Barrier Reef
Leader of the Opposition Anthony Albanese
22 JUN: Transcript of Interview with Murray Jones, 4CA Cairns
Subjects: G7, Member for New England, National Party Leader, COVID-19, Vaccine rollout, Hotel quarantine, Public health, Climate change, Net zero by 2050, Great Barrier Reef
Shadow Minister for Climate Change and Energy Chris Bowen
22 JUN: Transcript of Interview with Fran Kelly, ABC RN Breakfast
Subjects: COVID-19, Environment, Great Barrier Reef, National Party, Member for New England, Net-zero by 2050, Climate change
Shadow Minister for Housing and Homelessness Jason Clare
22 JUN: Transcript of Interview with Peter Stefanovic, Sky News First Edition
Subjects: National Party leadership spill, Member for New England, Climate change policy, Net zero emissions, Sexual assault, Women, Vaccine targets, NSW Budget
Member for Canberra Alicia Payne
22 JUN: Transcript of Interview with Rod Henshaw, 2CC Breakfast Show
Subjects: Vaccine advice, Public health campaign, Environmental laws review, National Party leadership spill, Aged care
Shadow Minister for Health and Ageing Mark Butler
22 JUN: Transcript of Doorstop Interview, Canberra
Subjects: Vaccine rollout, Moderna, COVID Taskforce, Pfizer vaccine demand, GP clinics, Quarantine facilities, Lieutenant General John Frewen, National Cabinet
Prime Minister Scott Morrison
21 JUN: Transcript of Interview with Ben Fordham, 2GB
Subjects: Foreign affairs, G7, UK Free Trade Agreement, China-Australia relations, Coronavirus WHO origins investigation, Vaccination rollout, QAnon, National Party leadership
Minister for International Development and the Pacific Zed Seselja
21 JUN: Transcript of Interview with Tahlea Aualiitia, ABC Pacific Beat
Subjects: Support for Fiji, Vaccine distribution in the Pacific, Travel bubbles, Agriculture ASEAN visa, Pacific labour migration, Pacific governance
Senator for NSW Tim Ayres
21 JUN: Transcript of Interview with Monte Irving, 2NZ Inverell
Subjects: National Party leadership, Mouse plague, NSW, Member for New England, Prime Minister, COVID-19, Public health, Economic recovery
Treasurer Josh Frydenberg
18 JUN: Transcript of Interview with Michael Rowland, News Breakfast, ABC
Subjects: Vaccine rollout, ATAGI advice, Labour force figures, Unemployment, Wage rises, Superannuation reforms
Treasurer Josh Frydenberg
18 JUN: Transcript of Interview with Sabra Lane, AM, ABC
Subjects: Superannuation reform, ATAGI vaccine advice, AstraZeneca vaccine hesitancy, Unemployment figures, Minimum wage boost, Wages growth
Treasurer Josh Frydenberg
18 JUN: Transcript of Interview with Peter Stefanovic, First Edition, Sky News
Subjects: Superannuation reform, Super industry regulation, Unemployment, Labour force figures, Wages growth, AstraZeneca vaccine hesitancy
Minister for Health and Aged Care Greg Hunt
18 JUN: Transcript of Press Conference with Chief Nursing and Midwifery Officer for Australia, Professor Alison McMillan, Canberra
Subjects: COVID-19, Vaccine rollout, National Cabinet, AstraZeneca, Pfizer
Minister for Trade, Tourism and Investment Dan Tehan
18 JUN: Transcript of Interview with Kelly Gudgeon, ABC Pilbara
Subjects: COVID-19 vaccine rollout, Australia-UK Free Trade Agreement, Agriculture visa, Quarantine, Storm damage in Victoria
Leader of the Opposition Anthony Albanese
18 JUN: Transcript of Doorstop Interview, Canberra
Subjects: Vaccine rollout, National quarantine, Health pandemic, Wellcamp proposal, Vaccine hesitance, AstraZeneca, MRNA vaccines
Shadow Assistant Treasurer Stephen Jones
18 JUN: Transcript of Interview with Marcus Paul, 2SM
Subjects: Superannuation reform, Industry regulation, Medicare cuts, MBS fee schedule changes, Vaccination rollout, Quarantine
VIC: COVID-19 Hotel Quarantine Inquiry
08 JUN: Transcript of Proceedings - Melbourne
Download
Return to top
Reports
Vyepti
Department of Health, Therapeutic Goods Administration (TGA)
Eptinezumab is a humanised immunoglobulin G1 (IgG1) antibody that binds to α- and β- forms of human calcitonin gene-related peptide (CGRP) ligand with low picomolar affinity preventing its activation of the CGRP receptors. Elevated blood concentrations of CGRP have been associated with migraine. Eptinezumab is highly selective and does not bind to any of the related neuropeptides amylin, calcitonin, adrenomedullin and intermedin.
Download
Nicotine Vaping Products & Vaping Devices - Guidance for the Therapeutic Goods (Standard for Nicotine Vaping Products) (TGO 110) Order 2021 & Related Matters - Version 1.1
Department of Health, Therapeutic Goods Administration (TGA)
The purpose of this guidance is to help health practitioners, consumers, importers and other sponsors, wholesalers and manufacturers to understand the minimum safety and quality requirements for unregistered nicotine vaping products and the regulation of vaping devices. This guidance includes:
- general information about Therapeutic Goods (Standard for Nicotine Vaping Products) (TGO 110) Order 2021 (TGO 110)
- information on the requirements for unregistered nicotine vaping products under TGO 110.
Download
Personalised medical devices (including 3D-printed devices) - Regulatory changes for custom-made medical devices - Version 3.0 - Paper
Department of Health, Therapeutic Goods Administration (TGA)
Personalised medical devices typically fall into one of two categories:
- those that are commonly used in clinical practice, but for which it is ideal to either produce or adapt/modify/assemble on a case-by-case basis to suit the anatomy or physiology of the patient (for example orthotics, dental crowns or sockets for prosthetic limbs); and
- those that are produced in circumstances where an individual's needs are so rare and unique that they cannot be catered to by any mass-produced medical devices.
Download
Fees and charges: summary
The Therapeutic Goods Administration
Download
Provisional Mortality Statistics
Australian Bureau of Statistics (ABS)
Key statistics
-33,575 deaths occurred by 31 March 2021 and were registered by 31 May.
-Numbers of deaths were above historical averages for each month of 2021.
-Numbers of deaths due to cancer, dementia and diabetes were above historical averages.
Download
Aged Care Legislation Amendment (Financial Transparency) Bill 2020
Senate Standing Committees on Community Affairs
The committee recommends that the Bill not be passed. The Bill seeks to introduce additional financial reporting requirements for providers of residential aged care in Australia in receipt of Commonwealth funding, with the aim of increasing financial transparency in the sector. The Government's aged care reform plan will be slow and, with respect to transparent financial information, is not responsive or detailed enough to meet the needs of residents and their families and does not meet community expectation.
Download
Drug use monitoring in Australia: Drug use among police detainees, 2020
Australian Institute of Criminology
The Drug Use Monitoring in Australia program involves the routine collection of survey and urinalysis data from police detainees across Australia. In 2020, almost half of the detainees reported using cannabis (47%) and methamphetamine (45%) in the past 30 days. Fewer detainees reported using benzodiazepines (21%), cocaine (8%), heroin (7%) or ecstasy (5%) in the past month. In the early stages of the COVID-19 pandemic, the availability and quality of methamphetamine and heroin declined. Past-month methamphetamine use, as confirmed by urinalysis results, also decreased from 55 percent in January-February to 38 percent in April-June.
Download
National Bowel Cancer Screening Program
Australian Institute of Health and Welfare
The National Bowel Cancer Screening Program (NBCSP) began in 2006. It aims to reduce the morbidity and mortality from bowel cancer by actively recruiting and screening the eligible target population, aged 50-74, for early detection or prevention of the disease. This monitoring report is the sixth to examine the NBCSP using the current key performance indicators. In 2021, it is estimated that about 7,365 people aged 50-74 will be diagnosed with bowel cancer (around 47% of all bowel cancers diagnosed) and 1,908 people in this age group will die from the disease (around 36% of all bowel cancer deaths).
Download
Australia's youth
Australian Institute of Health & Welfare (AIHW)
Adolescence and young adulthood is a critical period in a person's life. It is a time for finishing school, pursuing further training and education, entering the workforce, transitioning from dependence to independence and forming relationships. The foundations for future health and wellbeing are also laid down at this time. This report brings together a wide range of data on the wellbeing of young people aged 12-24. It also provides an overview of the impact of COVID-19 on young people. Highlights are presented in Australia's youth: in brief.
Download
Cancer Screening Programs - Quarterly Data
Australian Institute of Health & Welfare (AIHW)
This report presents the latest available activity and participation data for the 3 cancer screening programs: Activity data are presented to March 2021 for cervical and bowel cancer screening (breast cancer screening activity data are not available). Activity data are updated quarterly and were last updated on this page in June 2021. Participation data are presented to 2018-2019 for all 3 programs. Participation data for cervical and breast cancer screening were last updated in December 2020 and participation data for bowel cancer screening were last updated on this page in June 2021.
Download
NHMRC statement on iBlastoids
National Health and Medical Research Council (NHMRC)
Monash University's Polo Laboratory published research in the scientific journal Nature on 18 June 2021 (online) that demonstrates the creation of human embryo-like structures by reprogramming adult human skin cells. These structures are called iBlastoids by the research group because they are artificially induced and closely resemble human blastocysts (an early stage of human embryo development). iBlastoids can be created in large numbers in the laboratory, which is expected to allow researchers to more easily study early human development, and could be used for a number of other applications, such as development and/or mass screening of various drugs and therapies.
Download
VIC: Clinical Governance: Health Services
Victorian Auditor-General's Office
The safety and quality of Victorian health services is vital to all patients and their families and carers. It is therefore crucial that health services have rigorous clinical governance systems and cultures to deliver safe, person-centred and effective care. In 2016, the Victorian Government commissioned an independent review to assess how the then Department of Health and Human Services was overseeing the quality and safety of patient care across the state. This review, known as 'Targeting Zero', made many recommendations to improve the health sector and requested us to audit progress in addressing them.
Download
Return to top
Hansards
Federal
24 JUN 2021: REPS HANSARD: Questions Without Notice - COVID-19
24 JUN 2021: REPS HANSARD: Statements By Members - COVID-19: Vaccination
24 JUN 2021: REPS HANSARD: Questions Without Notice - COVID-19: Vaccination
24 JUN 2021: REPS HANSARD: Federation Chamber - Adjournment - Child Care - Medicare - Aged Care
24 JUN 2021: REPS HANSARD: Questions Without Notice - COVID-19: Quarantine
24 JUN 2021: REPS HANSARD: Federation Chamber - Adjournment - COVID-19: Vaccination
24 JUN 2021: REPS HANSARD: Statements By Members - Motor Neurone Disease
24 JUN 2021: REPS HANSARD: Statements By Members - Medicare
24 JUN 2021: REPS HANSARD: Bills - Medical and Midwife Indemnity Legislation Amendment Bill 2021 - Sydney Harbour Federation Trust Amendment Bill 2021 - Mutual Recognition Amendment Bill 2021 - Assent
24 JUN 2021: REPS HANSARD: Federation Chamber - Constituency Statements - Lyne Electorate: Health Services
24 JUN 2021: REPS HANSARD: Adjournment - COVID-19: Vaccination
24 JUN 2021: REPS HANSARD: Bills - Aged Care and Other Legislation Amendment (Royal Commission Response No. 1) Bill 2021 - Returned from Senate
24 JUN 2021: REPS HANSARD: Adjournment - Silicosis
24 JUN 2021: SENATE HANSARD: Bills - Aged Care and Other Legislation Amendment (Royal Commission Response No. 1) Bill 2021 - Second Reading, Third Reading
24 JUN 2021: SENATE HANSARD: Questions Without Notice - COVID-19: Vaccination
23 JUN 2021: REPS HANSARD: Statements By Members - COVID-19: Vaccination
24 JUN 2021: REPS HANSARD: Federation Chamber - Constituency Statements - Palmer, Mr Clive - COVID-19: Vaccination
24 JUN 2021: REPS HANSARD: Federation Chamber - Adjournment - Euthanasia
23 JUN 2021: SENATE HANSARD: Questions Without Notice - Aged Care
23 JUN 2021: SENATE HANSARD: Questions Without Notice - COVID-19: Vaccination
23 JUN 2021: SENATE HANSARD: Questions Without Notice - Take Note of Answers - COVID-19: Vaccination
23 JUN 2021: REPS HANSARD: Federation Chamber - Private Members' Business - Veterans: Veteran Wellbeing Centres
23 JUN 2021: REPS HANSARD: Questions Without Notice - COVID-19: Vaccination - COVID-19: Quarantine
23 JUN 2021: REPS HANSARD: Questions Without Notice - COVID-19: Vaccination
23 JUN 2021: REPS HANSARD: Questions Without Notice - COVID-19: Vaccination
23 JUN 2021: REPS HANSARD: Motions - COVID-19
22 JUN 2021: REPS HANSARD: Adjournment - Hospitality Industry
22 JUN 2021: SENATE HANSARD: Motions - Medicare Benefits Scheme
22 JUN 2021: SENATE HANSARD: Documents - COVID-19: Vaccination - Order for the Production of Documents
22 JUN 2021: REPS HANSARD: Statements by Members - COVID-19, Vaccination
21 JUN 2021: REPS HANSARD: Federation Chamber - Statements By Members - Goldstein Electorate: Sandringham Hospital
21 JUN 2021: REPS HANSARD: Petitions - Health Care
21 JUN 2021: REPS HANSARD: Adjournment - Shortland Electorate: Health
21 JUN 2021: REPS HANSARD: Petitions - Private Health Insurance
21 JUN 2021: REPS HANSARD: Statements By Members - Health Care
21 JUN 2021: REPS HANSARD: Statements By Members - Groom Electorate: Mental Health
21 JUN 2021: REPS HANSARD: Federation Chamber - Constituency Statements - Health Care
21 JUN 2021: REPS HANSARD: Petitions - Responses - Rural and Regional Services: Health
21 JUN 2021: REPS HANSARD: Petitions - Responses - Men's Health and Wellbeing
21 JUN 2021: REPS HANSARD: Statements By Members - Rural and Regional Health Services
21 JUN 2021: REPS HANSARD: Federation Chamber - Adjournment - South Australia: Health Care
21 JUN 2021: REPS HANSARD: Statements By Members - Gilmore Electorate: Health
New South Wales
24 JUN 2021: NSW ASSEMBLY HANSARD: Announcements - COVID-19
23 JUN 2021: NSW ASSEMBLY HANSARD: Announcements - Emergency Services Medal
23 JUN 2021: NSW ASSEMBLY HANSARD: Announcements - COVID-19
23 JUN 2021: NSW ASSEMBLY HANSARD: Private Members' Statements - Canterbury Hospital
23 JUN 2021: NSW ASSEMBLY HANSARD: Question Time - COVID-19
23 JUN 2021: NSW ASSEMBLY HANSARD: Community Recognition Notices - Tweed Vaccination Clinic
22 JUN 2021: NSW ASSEMBLY HANSARD: Question Time - State Budget and Health Infrastructure
22 JUN 2021: NSW ASSEMBLY HANSARD: Community Recognition Notices - Shoalhaven Emergency Services Community Awards
22 JUN 2021: NSW ASSEMBLY HANSARD: Community Recognition Statements - Cancer Council
22 JUN 2021: NSW COUNCIL HANSARD: Questions Without Notice: Take Note - Banksia Mental Health Unit
22 JUN 2021: NSW COUNCIL HANSARD: Questions Without Notice: Take Note - Liverpool Health and Academic Precinct
22 JUN 2021: NSW COUNCIL HANSARD: Questions Without Notice - Banksia Mental Health Unit
22 JUN 2021: NSW COUNCIL HANSARD: Questions Without Notice - State Budget and Mental Health
Victoria
24 JUN 2021: VIC COUNCIL HANSARD: Questions Without Notice and Ministers Statements - COVID-19
24 JUN 2021: VIC COUNCIL HANSARD: Members Statements - COVID-19 Vaccination
24 JUN 2021: VIC COUNCIL HANSARD: Questions Without Notice and Ministers Statements - Melbourne Medically Supervised Injecting Facility
24 JUN 2021: VIC ASSEMBLY HANSARD: Adjournment - Dental Services
24 JUN 2021: VIC ASSEMBLY HANSARD: Adjournment - Mental Health Funding
23 JUN 2021: VIC COUNCIL HANSARD: Adjournment - COVID-19
23 JUN 2021: VIC ASSEMBLY HANSARD: Petitions - Breast Screening
23 JUN 2021: VIC COUNCIL HANSARD: Motions - Alcohol and Other Drug Programs
23 JUN 2021: VIC ASSEMBLY HANSARD: Adjournment - Mental Health Funding
23 JUN 2021: VIC ASSEMBLY HANSARD: Members Statements - Emergency Services Workers
23 JUN 2021: VIC COUNCIL HANSARD: Statements on Reports, Papers & Petitions - Department of Health - 14th Report to Parliament on the State of Emergency
23 JUN 2021: VIC COUNCIL HANSARD: Questions Without Notice & Ministers Statements - Medicinal Cannabis
23 JUN 2021: VIC COUNCIL HANSARD: Adjournment - mRNA Victoria
23 JUN 2021: VIC ASSEMBLY HANSARD: Members Statements - Loddon Campaspe Health Workforce
23 JUN 2021: VIC COUNCIL HANSARD: Adjournment - COVID-19 Vaccination
22 JUN 2021: VIC ASSEMBLY HANSARD: Members Statements - COVID-19 Vaccinations
22 JUN 2021: VIC COUNCIL HANSARD: Announcements - COVID-19
22 JUN 2021: VIC COUNCIL HANSARD: Adjournment - COVID-19
22 JUN 2021: VIC ASSEMBLY HANSARD: Adjournment - COVID-19
22 JUN 2021: VIC COUNCIL HANSARD: Members Statements - Men's Health Week
22 JUN 2021: VIC COUNCIL HANSARD: Adjournment - COVID-19 Vaccination
South Australia
22 JUN 2021: SA ASSEMBLY HANSARD: Question Time - Medicare Rebate Scheme
22 JUN 2021: SA COUNCIL HANSARD: Question Time - Ambulance Ramping
22 JUN 2021: SA COUNCIL HANSARD: Question Time - Women's and Children's Hospital
22 JUN 2021: SA COUNCIL HANSARD: Question Time - COVID-19, Hotel Quarantine
22 JUN 2021: SA COUNCIL HANSARD: Question Time - Cystic Fibrosis
22 JUN 2021: SA COUNCIL HANSARD: Question Time - COVID-19 Vaccination Rollout
22 JUN 2021: SA ASSEMBLY HANSARD: Question Time - Women's and Children's Hospital
22 JUN 2021: SA ASSEMBLY HANSARD: Question Time - Ambulance Ramping
22 JUN 2021: SA ASSEMBLY HANSARD: Question Time - COVID-19 Vaccination Rollout
22 JUN 2021: SA COUNCIL HANSARD: Question Time - Disability Services
Western Australia
24 JUN 2021: WA COUNCIL HANSARD: Questions Without Notice - Voluntary Assisted Dying - Practitioner Training
24 JUN 2021: WA COUNCIL HANSARD: Questions Without Notice - Medical Cannabis - Opioid-Related Mortality Rates
22 JUN 2021: WA COUNCIL HANSARD: Questions Without Notice - Coronavirus, Vaccination Clinics, Regions
Return to top
Court Cases
None this edition.
Return to top
New Regulations
Federal
Health Insurance Legislation Amendment (Section 3C General Medical Services - Medicare Indexation & Extension of Remote Service Options) Determination 2021
Legislative Instrument - F2021L00822
The purpose of the Health Insurance Legislation Amendment (Section 3C General Medical Services - Medicare Indexation and Extension of Remote Service Options) Determination 2021 (the Amendment Determination) is to extend access to certain medical practitioner and allied health telehealth and phone services until 31 December 2021, change the types of general practice telehealth and phone services available to patients, and to apply annual indexation of Medicare benefits.
Explanatory Statement
Health Insurance (Section 3C General Medical Services - Anterior and Posterior Pelvic Ring Disruption) Determination 2021
Legislative Instrument - F2021L00821
The Health Insurance (Section 3C General Medical Services - Anterior and Posterior Pelvic Ring Disruption) Determination 2021 (the Determination) lists one new item 47491, which is an orthopaedic paediatric item for the treatment of a fracture by a pelvic ring disruption. This change is part of the Government's response to recommendations from the MBS Review Taskforce (the Taskforce) relating to orthopaedic services.
Explanatory Statement
National Health (Take Home Naloxone Pilot) Special Arrangement Amendment (2021 Measures No. 1) Instrument 2021
Legislative Instrument - F2021L00820
The National Health (Take Home Naloxone Pilot) Special Arrangement Amendment (2021 Measures No.1) Instrument 2021 (PB 69 of 2021) (the Amendment Instrument) amends the National Health (Take Home Naloxone Pilot) Special Arrangement 2019 (PB 97 of 2019) (the Arrangement) to continue the arrangements of the Take Home Naloxone Pilot Program (the Pilot) in 2021-22.
Explanatory Statement
National Health (Closing the Gap - PBS Co-payment Program) Amendment Special Arrangement 2021
Legislative Instrument Compilation - F2021L00819
The National Health (Closing the Gap - PBS Co-payment Program) Amendment Special Arrangement 2021 (Amendment Instrument) amends the National Health (Indigenous Chronic Disease - PBS Co-payment Measure) Special Arrangement 2016 (Special Arrangement). The Amendment Instrument makes changes associated with reforms to the Closing the Gap (CTG) Pharmaceutical Benefits Scheme (PBS) Co-payment Program. These amendments resulted from changes to enhance the CTG PBS Co-payment Program announced through the Seventh Community Pharmacy Agreement (7CPA) in June 2020.
Explanatory Statement
Health Insurance (Bonded Medical Program) Amendment (Extension of Transitional Provisions) Rule 2021
Legislative Instrument - F2021L00816
This Rule (the Amendment Rule) amends the Health Insurance (Bonded Medical Program) Rule 2020 (the Principal Rule) to extend the time during which the transitional provisions in section 19 apply. Part VD of the Act establishes the Bonded Medical Program, which is an Australian Government initiative designed to address the doctor shortage across regional, rural and remote areas.
Explanatory Statement
Health Insurance (Quality Assurance Activity - Australian and New Zealand Audits of Surgical Mortality) Amendment Declaration 2021
Legislative Instrument - F2021L00815
The Health Insurance (Quality Assurance Activity - Australian and New Zealand Audits of Surgical Mortality) Amendment Declaration 2021 (the Declaration) is an amending declaration made under subsection 124X(1) of the Health Insurance Act 1973 (the Act). Part VC of the Act creates a scheme to encourage efficient quality assurance activities in connection with the provision of health services. Those activities help to ensure the quality of health services that are funded by the Government, including through the Medicare Benefits Schedule, public hospital services, and Health Program Grants.
Explanatory Statement
Health Insurance (Section 3C General Medical Services - Transcatheter Mitral Valve Repair) Determination 2021
Legislative Instrument - F2021L00800
The Health Insurance (Section 3C General Medical Services - Transcatheter Mitral Valve Repair) Determination 2021 (the Determination) lists four new items (6082, 6084, 38461 and 38463) to enable symptomatic patients who have moderate-severe or severe degenerative (primary) mitral valve regurgitation, or symptomatic patients who have moderate-severe or severe functional (secondary) mitral valve regurgitation to undergo a transcatheter mitral valve repair (TMVr) with the MitraClip system.
Explanatory Statement
National Health (Remote Area Aboriginal Health Services Program) Amendment Special Arrangement 2021 (No. 1)
Legislative Instrument - F2021L00787
The National Health (Remote Area Aboriginal Health Services Program) Amendment Special Arrangement 2021 (No. 1) (the Amendment Instrument) amends the National Health (Remote Area Aboriginal Health Services Program) Special Arrangement (PB 107 of 2017) (the Special Arrangement). The Amendment Instrument increases the bulk handling fee and the patient specific medicine supply fee that is payable to an approved pharmacist or an approved hospital authority in respect of the supply of a pharmaceutical benefit to an approved Aboriginal Health Service in accordance with the Special Arrangement.
Explanatory Statement
Social Security (Special Disability Trust - Discretionary Spending) Determination 2021
Legislative Instrument - F2021L00784
The purpose of the Social Security (Special Disability Trust - Discretionary Spending) Determination 2021 (this instrument) is to set out the maximum amount of a special disability trust's income and / or assets that can be spent for purposes that are primarily for the benefit of the principal beneficiary, but are purposes other than the primary purpose of the special disability trust (the Discretionary Spending Limit) described in subsection 1209N(1) of the Social Security Act 1991 (the Act).
Explanatory Statement
Victoria
18 JUN 2021: VIC SPECIAL GAZETTE No. S 313: Public Health and Wellbeing Act 2008 - Section 200 - Directions from Chief Health Officer in Accordance with Emergency Powers Arising from Declared State of Emergency
Western Australia
18 JUN 2021: WA, GOVERNOR IN EXECUTIVE COUNCIL: Health Services Act 2016 - Health Services (Health Service Providers) Amendment Order (No. 3) 2021 - SL 2021/97
18 JUN 2021: WA, GOVERNOR IN EXECUTIVE COUNCIL: Voluntary Assisted Dying Act 2019 - Commencement Proclamation 2021 - SL 2021/83
18 JUN 2021: WA, GOVERNOR IN EXECUTIVE COUNCIL: Health (Miscellaneous Provisions) Act 1911 - Health (Aquatic Facilities) Amendment Regulations 2021 - SL 2021/72
Return to top
Proclamations
None this edition.
Return to top
Gazette Notices
New South Wales
20 JUN 2021: NSW GOVERNMENT GAZETTE No. 264: Government Notices - Health and Education
Return to top
Consolidated Legislation
Private Health Insurance (Prostheses) Rules (No. 3) 2020
Legislative Instrument Compilation - F2021C00552
Rules/Other as amended, taking into account amendments up to Private Health Insurance (Prostheses) Amendment Rules (No. 1) 2021.
Download
Health Insurance (General Medical Services Table) Regulations (No. 2) 2020
Legislative Instrument Compilation - F2021C00551
Regulations as amended, taking into account amendments up to Health Insurance Legislation Amendment (2020 Measures No. 3) Regulations 2020.
Download
Records Principles 2014
Legislative Instrument Compilation - F2021C00531
Principles as amended, taking into account amendments up to Aged Care Legislation Amendment (Service Staff Vaccination Recording and Reporting) Principles 2021.
Download
Return to top
New Bills
Federal
A Bill for an Act to amend the law relating to aged care, and for related purposes
The purpose of the Bill is to provide urgent amendments to the Aged Care Act 1997 (Aged Care Act) and the Aged Care Quality and Safety Commission Act 2018 (Quality and Safety Commission Act) in response to the Royal Commission into Aged Care Quality and Safety (Royal Commission).
The Bill provides the first stage of aged care reform in response to the Royal Commission's final report, strengthens the Australian Government's ongoing commitment to ensuring senior Australians get the high quality and safe aged care services they deserve.
The amendments introduced by Schedule 1 of the Bill will strengthen the responsibilities under the Aged Care Act on approved providers of aged care of a type specified in the Quality of Care Principles 2014 (Quality of Care Principles) by including enhanced safeguards and conditions on the use of restrictive practices. The Bill undertakes to emphasise person-centred care in relation to the use of restrictive practices through inserting a new definition of 'restrictive practice' and requiring the Quality of Care Principles to provide legislative detail on the requirements approved providers are to comply with prior to, during, and after the use of restrictive practices.
The Bill will also enhance compliance of approved providers by including civil penalties for those providers who fail to comply with compliance notices produced by the Aged Care Quality and Safety Commissioner (Commissioner) in relation to a breach of restrictive practice responsibilities under the Aged Care Act.
Schedule 2 of the Bill amends the Aged Care Act to empower the Secretary to conduct reviews (assurance reviews) to assure the arrangements for the delivery and administration of home care are effective and efficient. Assurance reviews will inform the continuous improvement of home care policy and the education of approved providers in relation to home care and home care services.
The Secretary, or appropriate delegate, will be able to issue 'notices to give' and 'notices to attend' to approved providers that are corporations to collect information in relation to an assurance review. Approved providers that are corporations will be required to provide all reasonable facilities and assistance to the Secretary, and persons assisting the Secretary, in their performance of the reviews. Failure to comply with these notices or provide reasonable assistance will incur civil penalties. The Secretary will also be able to request that a person (or approved provider that is not a corporation) to provide any information or documents that are relevant to an assurance review. The person is not required to comply with the request.
The Secretary or persons assisting the Secretary may prepare and publish reports on assurance reviews, dealing with findings, conclusions or recommendations made as a result of the reviews. The report may be published where no identifying personal information is included. The Secretary may publish information on providers who do not comply with notices to produce information or provide reasonable assistance. The assurance reviews will provide transparency for consumers and increased program oversight for the Government.
On 13 May 2021, the provisions of the Bill were referred to the Senate Community Affairs Legislation Committee for inquiry and report by 11 June 2021.
Reps: Intro 27/05/21, 2R 27/05/21, 21/06/21, Passed 21/06/21
Senate: Intro 23/06/21, 2R 24/06/21, Passed 24/06/21
Awaiting assent
Assent TBA, Act No. TBA
Commencement:
- Sections 1 to 3 and anything in this Act not elsewhere covered by this table - The day this Act receives the Royal Assent.
- Schedule 1 - 1 July 2021.
- Schedule 2 - The day after this Act receives the Royal Assent.
- Schedule 3 - 1 July 2021.
A Private Member's Bill (Griff) for an Act to amend the law in relation to financial transparency in the aged care sector, and for related purposes.
This Bill amends the Aged Care Act 1997 to require residential aged care providers to give an annual financial transparency report to the Aged Care Quality and Safety Commissioner, who would then make them public. The Bill also amends the Corporations Act 2001 to ensure residential aged care providers include detailed financial information in their annual financial statements.
The Bill requires aged care providers to disclose their income, their spend on food and medication, the amount spent on staff and staff training, accommodation, administration, and how much they pay out to their parent bodies.
This will enable families of loved ones, stakeholders and the public to have a clear view, for the first time, on the proportion of income that providers actually spend on costs of care and how much is just being pocketed or wasted.
On 18 June 2020, the Senate Selection of Bills Committee referred the Bill to the Community Affairs Legislation Committee for inquiry and report by 23 November 2020.
The reporting date was extended to the last sitting day in March 2021.
Senate: Intro 12/06/20, 2R 12/06/20, 30/11/20, Passed TBA
Reps: Intro TBA, 2R TBA, Passed TBA
Assent TBA, Act No. TBA
Commencement: The day after this Act receives the Royal Assent.
A Private Member's Bill (Kelly) for an Act to protect the right of Australians to make their own health decisions in relation to COVID vaccination, and for related purposes.
This Bill prohibits the Commonwealth, States and Territories and other non-government entities from issuing domestic vaccine passports or certification and also prohibits discrimination on the basis of whether a person has had a COVID vaccination in the provision of goods, services and facilities and also in employment, education, accommodation and sport.
A system of vaccine passports risks creating two classes of citizens and this Bill is necessary to protect the fundamental rights and privacies of all Australians and the free flow of people and commerce throughout the nation.
Reps: Intro 21/06/21, 2R 21/06/21, Passed TBA
Senate: Intro TBA, 2R TBA, Passed TBA
Assent TBA, Act No. TBA
Commencement: The whole of this Act - The day after this Act receives the Royal Assent.
A Bill for an Act to amend the Private Health Insurance Act 2007, and for other purposes
The Bill implements the 2020-21 Budget measure, 'Supporting Our Hospitals - simpler and more affordable private health cover for all Australians', of which 'Private Health Insurance - increasing the age of dependants' was an element.
The Bill amends the Private Health Insurance Act 2007 and associated legislation to:
- change the maximum allowable age for people to be covered under a family private health insurance policy as a dependent from up to 24 years old to up to 31 years old;
- allow people with a disability, regardless of their age, to be covered under a family private health insurance policy as a dependent.
Reps: Intro 25/02/21, 2R 25/02/21, 18/03/21, Passed 18/03/21
Senate: Intro 18/03/21, 2R 18/03/21, 22/06/21, Passed 22/06/21
Assent TBA, Act No. TBA
Commencement: The whole of this Act: 1 April 2021
A Bill for an Act to amend the law relating to taxation, social security, veterans' entitlements and the National Housing Finance and Investment Corporation, and for related purposes.
Schedule 1 of the Bill amends the Medicare Levy Act 1986 and the A New Tax System (Medicare Levy Surcharge - Fringe Benefits) Act 1999 to:
- increase the Medicare levy low-income thresholds for individuals and families (along with the dependent child-student component of the family threshold) in line with movements in the CPI;
- increase the Medicare levy low-income thresholds for individuals and families eligible for the SAPTO (along with the dependent child-student component of the family threshold), in line with movements in the CPI; and
- increase the Medicare levy surcharge low-income threshold in line with movements in the CPI.
This will ensure that low-income individuals, families, seniors and pensioners who were exempt from the Medicare levy in the 2019-20 income year continue to be exempt in the 2020-21 income year if their income has increased in line with, or less than, movements in the CPI.
Schedule 2 of the Bill amends the NHFIC Act to expand the objects of the Act to include NHFIC improving housing outcomes for Australians by assisting earlier access to the housing market by eligible single parents with dependants. The amendments to the objects will enable the Minister to issue directions to NHFIC through its Investment Mandate.
Schedule 3 of the Bill amends the ITAA 1997, the SS Act and the Veteran's Entitlements Act 1986 to provide that annual and lump sum payments made by the Commonwealth to Thalidomide survivors are exempt from income tax and do not count as income for the purposes of any income support payments.
Reps: Intro 13/05/21, 2R 13/05/21, 26/05/21, 27/05/21, Passed 27/05/21
Senate: Intro 15/06/21, 2R 15/06/21, 22/06/21, Passed 22/06/21
Awaiting Assent
Assent TBA, Act No. TBA
Commencement:
Sections 1 to 3 and anything in this Act not elsewhere covered by this table - The day this Act receives the Royal Assent.
Schedule 1 - The day after this Act receives the Royal Assent.
Schedule 2 - The later of:
(a) 1 July 2021; and
(b) the day after this Act receives the Royal Assent.
Schedule 3, Part 1 - The first 1 January, 1 April, 1 July or 1 October to occur after the day this Act receives the Royal Assent.
Schedule 3, Part 2 - The day after this Act receives the Royal Assent.
Schedules 4 and 5 - The first 1 January, 1 April, 1 July or 1 October to occur after the day this Act receives the Royal Assent.
ACT
A Bill for An Act to amend the Senior Practitioner Act 2018.
The Senior Practitioner Act 2018 (the Act) commenced on 1 September 2018. The Act created the role of the Senior Practitioner, as well as providing a formal framework for the reduction and elimination of restrictive practices.
The amendments contained in the Bill are administrative and delay the review of the Act until after its fifth year of operation. Currently, a review of the Act must be presented by the Minister for Disability as soon as is practical after the Act's third year of operation. Without amendment, this would be due in September 2021.
In addition to delaying the review and report on the operation of the Act, this Bill necessarily delays the expiry of the corresponding sunset provision as follows:
- Section 54 (1) states that 'the Minister must review the operation of this Act and present a report of the review to the Legislative Assembly as soon as practicable after the end of its 3rd year of operation'. The Bill amends this time frame to the 5th year of operation.
- Section 54 (2) states that 'this section expires 4 years after the date it commences'. The Bill extends the expiry of Section 54 to the 6th year of operation.
Intro 24/06/21, 2R 24/06/21, Passed TBA
Notified TBA, Act No. TBA
Commencement: This Act commences on the day after its notification day.
South Australia
A Private Member's Bill (Maher) for An Act to provide for and regulate access to voluntary assisted dying, to establish the Voluntary Assisted Dying Review Board, to make related amendments to other Acts, and for other purposes.
The main purpose of this Bill is to introduce a voluntary assisted dying scheme, modelled on that implemented in Victoria. The essential elements, as described by the Victorian health department, for someone seeking access to the Victorian scheme include:
- they must have an advanced disease that will cause their death, and is likely to cause that within six months, or 12 months if a neurodegenerative disease, that is causing that person suffering that is unacceptable to them;
- they must have the ability to make and communicate a decision about voluntary assisted dying through the formal request process; and
- they must be an adult over 18 years, have been living in the state for at least 12 months, and be an Australian citizen or permanent resident.
LC: 1R 02/12/20, 2R 02/12/20, 17/03/21, 31/03/21, 05/05/21, Passed (with amendments) 05/05/21
LA: 1R 06/05/21, 2R 12/05/21, 26/05/21, 09/06/21, Passed (with amendments) 09/06/21
LC: Consideration of amendments 10/06/21, Agreed to amendments 1, 2, 4, & 5 and amended amendment 3 23/06/21
LA: Consideration of amendments 23/06/21
LC: Final Stages TBA
Assent TBA, Act No. TBA
Commencement: This Act comes into operation on a day to be fixed by proclamation.
Western Australia
A Bill for An Act to amend the Health Services Act 2016; and the Mental Health Act 2014; and the Motor Vehicle (Catastrophic Injuries) Act 2016; and the Queen Elizabeth II Medical Centre Act 1966; and the University Medical School, Teaching Hospitals, Act 1955.
The Health Services Amendment Bill 2021 (the Bill) amends the Health Services Act 2016 (the Act) to refine the Act's effectiveness. The Bill amends the functions and powers of the Minister for Health (the Minister), the Department CEO and health service providers (HSPs) to improve the functioning of the WA health system and to overcome operational and administrative burdens that have been encountered since the Act commenced. It also rectifies drafting errors and amends the parts of the Act that have not been operationalised effectively due to ambiguous interpretation.
LA: Notice of Motion 23/06/21
LA: 1R 24/06/21, 2R 24/06/21, Passed TBA
LC: 1R TBA, 2R TBA, Passed TBA
Assent TBA, Act No. TBA
Commencement: This Act comes into operation as follows -
(a) Part 1 - on the day on which this Act receives the Royal Assent;
(b) the rest of the Act - on a day fixed by proclamation, and different days may be fixed for different provisions.
A Bill for An Act to amend the Public Health Act 2016.
The Bill amends the Public Health Act 2016 (the PHA) to create safe access zones around premises at which abortions are provided. These zones will ensure that those who want to access abortion services can do so in a safe and private manner. The Bill also prohibits publication and distribution of certain recordings to protect the privacy and dignity of those who access abortion services.
LA: Notice of Motion 25/05/21
LA: 1R 26/05/21, 2R 26/05/21, 23/06/21, 24/06/21, Passed 24/06/21
LC: 1R 24/06/21, 2R 24/06/21, Passed TBA
Assent TBA, Act No. TBA
Commencement: This Act comes into operation as follows -
(a) sections 1 and 2 - on the day on which this Act receives the Royal Assent;
(b) the rest of the Act - on the day after that day.
Return to top
New Acts
Federal
Medical and Midwife Indemnity Legislation Amendment Act 2021
An Act to amend the law relating to medical and midwife indemnity, and for related purposes
The purpose of the Act is to ensure that claims made against all privately practising midwives are eligible under the Commonwealth's medical and midwife indemnity schemes.
The Act amends the Medical Indemnity Act 2002 to ensure that claims against all midwives in private practice whose registration is not endorsed by the Nursing and Midwifery Board of Australia to prescribe scheduled medicines (registered only midwives) are eligible under the Allied Health High Cost Claims Scheme and the Allied Health Exceptional Claims Scheme (Allied Health Schemes) where the claim relates to incidents that occurred on or from 1 July 2020. Previously, claims against some registered only midwives were not eligible for the Allied Health Schemes based on whether the midwife could be expected to be covered by an employer's indemnity arrangements.
These amendments ensure that the medical indemnity legislation reflects the Commonwealth's policy that claims against all registered only midwives have coverage under the Allied Health Schemes for claims made after the commencement of those Schemes on 1 July 2020, creating parity of arrangements with all other registered allied health professionals eligible under the Allied Health Schemes.
The Act also amends the Midwife Professional Indemnity (Commonwealth Contribution) Scheme Act 2010 to expand eligibility of the Midwife Professional Indemnity Scheme and the Midwife Professional Indemnity Run-off Cover Scheme (Midwife Schemes) to cover claims made against midwives in private practice whose registration has been endorsed by the Nursing and Midwifery Board of Australia to prescribe scheduled medicines (eligible midwives), irrespective of whether the midwife is covered under a professional indemnity insurance policy as an employee or in an independent capacity.
The Aboriginal Community Controlled Health Services have requested Government support for access to an insurance product for their employed midwives. This cohort of midwives are unable to obtain indemnity insurance to extend their services to intrapartum care under an indemnity insurer. The Department has worked closely with a number of the Aboriginal Community Controlled Health Services and the provider currently administering the Midwife Scheme, Medical Insurance Group Australia Pty Ltd, to support the development of an appropriate insurance product to cover these health services and their midwifery services. This measure will open-up the Midwife Professionals Indemnity Scheme to all endorsed midwives irrespective of their employment status, and provide access to an insurance policy for this class of midwives that includes intrapartum care (with the exception of homebirths).
The Department also provided advice to key stakeholders to outline the changes to be made in the medical and midwife indemnity legislation and invited these stakeholders to provide written feedback. The stakeholders contacted during this process included the Australian College of Midwives and medical indemnity insurers including, Avant, Berkshire Hathaway, Guild Insurance, Medical Indemnity Protection Society, MDA National and Medical Insurance Group Australia Pty Ltd.
As a result of these amendments, the eligible insurer under the Midwife Professional Indemnity (Commonwealth Contribution) Scheme Act 2010, currently Medical Insurance Group Australia Pty Ltd, will be able to indemnify employed endorsed midwives under the Midwife Schemes. This ensures that these midwives are covered by an insurance policy that has capped premiums and eligibility to the Midwife Professional Indemnity Run-off Cover Scheme.
Employed eligible midwives currently not participating in the Midwife Schemes will have the choice to stay under their current arrangements, and if an eligible claim was made in these circumstances the Allied Health Schemes would respond. This flexibility in arrangements supports midwives to work in a variety of different arrangements, without their indemnity insurance being a barrier.
Amendments made by this Act will mean that claims against all privately practising midwives will be eligible under the Commonwealth's medical and midwife indemnity schemes if an eligible medical indemnity claim is made.
Reps: Intro 27/05/21, 2R 27/05/21, 16/06/21, 17/06/21, Passed 17/06/21
Senate: Intro 17/06/21, 2R 17/06/21, Passed 17/06/21
Awaiting assent
Assent 23/06/21, Act No. 48 of 2021
Commencement:
- Sections 1 to 3 and anything in this Act not elsewhere covered by this table - The day this Act receives the Royal Assent.
- Schedule 1 - 1 July 2020.
- Schedule 2 - 1 July 2021.
Private Health Insurance Amendment (Income Thresholds) Act 2021
An Act to amend the Private Health Insurance Act 2007, and for related purposes
The Act continues the pause of the annual indexation of private health insurance (PHI) income thresholds for another two years, and adjusts the formula for recommencement of indexation at the current income thresholds following the end of the pause.
The Private Health Insurance Act 2007 (the Act) is the main law that sets out the requirements for PHI and health insurers. The Act allows for the setting and annual indexing of income thresholds. The income thresholds determine rebate amounts that may apply for consumers with eligible PHI cover (the PHI rebate), and the Medicare Levy Surcharge (MLS) income thresholds and rates.
Indexation of income thresholds
Annual indexation of income thresholds is provided for under Subdivision 22-B (the Subdivision) of the Act. The thresholds for annual indexation of Singles and Family thresholds and the details of indexation are specified under Subsection 22-35, 22-40, and 22-45 provisions respectively.
The Act continues the pause of the annual indexation of income thresholds for another two years, and adjusts the formula for recommencement of indexation. The Government has announced that the continuation of the pause will provide an opportunity to undertake a detailed study of settings of the PHI rebate and the MLS.
With the pause, rebate income thresholds remain at $90,000 for the base single policy and at $180,000 for the base family policy. Base income threshold (under which a taxpayer is not liable to pay the MLS) remains at $90,000 for singles and at $180,000 for families.
Specifically the Act seeks to amend the Act to:
- pause indexation for a further two financial years
- recommence annual indexation thereafter
- recommence indexation using current income thresholds
- repeal consequential redundant Subdivision 22-B provisions.
Reps: Intro 12/05/21, 2R 27/05/21, 01/06/21, Passed 01/06/21
Senate: Intro 15/06/21, 2R 15/06/21, 17/06/21, Passed 17/06/21
Assent 25/06/21, Act No. 52 of 2021
Commencement: The whole of this Act - 1 July 2021.
Narcotic Drugs Amendment (Medicinal Cannabis) Act 2021
An Act to amend the Narcotic Drugs Act 1967, and for related purposes
The Narcotic Drugs Act 1967 (ND Act), as amended by the Narcotic Drugs Amendment Act 2016 (2016 Amendment Act), establishes a licensing scheme for the cultivation and production of cannabis and cannabis resin for medicinal and scientific purposes. The ND Act also makes provisions for licensing the manufacture of other narcotic drugs.
The 2016 Amendment Act introduced a requirement for a review of the medicinal cannabis scheme to be undertaken. This was completed by Professor John McMillan AO, and the Final Report of the McMillan Review was tabled in the Parliament on 5 September 2019.
The Act implements recommendations of the McMillan Review, and makes other minor including consequential amendments.
As a large portion of the amendments reorganise the scheme as set up by the 2016 Amendment Act, the human rights implications are materially the same as those identified in relation to the Act which became the 2016 Amendment Act.
The amendments in the Act contribute to ensuring that the regulatory framework strikes a balance between mitigating the risk to the Australian community of the diversion of cannabis and Australia's obligations under international law, with the need to ensure that medicinal cannabis regulation in Australia facilitates ease of compliance for industry participants and does not impede growth and productivity.
The two main measures in the Act are to:
1. consolidate the licensing structure into a single licence framework instead of the current three-licence structure, to reduce the regulatory burden on industry participants who are undertaking activities across the spectrum of cultivation, production and manufacture; and
2. undertake assessments relating to supply chains later in the application process, at consideration of applications for a permit rather than the earlier licensing stage, to support the long term nature of business investment decisions, whilst maintaining appropriate regulatory oversight.
Reps: Intro 03/02/21, 2R 03/02/21, 24/02/21, Passed 24/02/21
Senate: 25/02/21, 2R 25/02/21, 17/06/21, Passed 17/06/21
Assent 25/06/21, Act No. 56 of 2021
Commencement:
- Sections 1 to 3 and anything in this Act not elsewhere covered by this table - The day this Act receives the Royal Assent.
- Schedules 1 and 2 - A single day to be fixed by Proclamation. However, if the provisions do not commence within the period of 6 months beginning on the day this Act receives the Royal Assent, they commence on the day after the end of that period.
Western Australia
An Act to protect the confidentiality of certain information obtained for the purposes of contact tracing relating to COVID-19 and other infectious diseases.
The Act provides a statutory framework for regulating the use and disclosure, storage and destruction of entry registration information provided for the purpose of contact tracing in relation to an infectious disease emergency.
The Act introduces specific protection for entry registration information in recognition of the importance of this information for an effective public health response to a public health emergency and the critical importance of maintaining trust in measures imposed and mandated by government to combat the risks posed by community transmission of an infectious disease.
The Act limits the use and disclosure of entry registration information to contact tracing and purposes related to contact tracing, reflecting that public health is the paramount consideration.
Specifically the Act prohibits the use and disclosure of entry registration information supplied by individuals upon their attendance at a place, for any purpose other than:
- conducting contact tracing;
- purposes related to contact tracing (such as, but not limited to, the support, efficacy, integrity and security of contact tracing);
- deriving de-identified statistical or summary information; or
- investigating or prosecuting an offence related to an obligation to provide or record information for the purpose of contact tracing, an offence under this Bill; an offence related to compliance with an obligation related to the recording, use or disclosure of contact tracing information, or for an offence of giving false or misleading information when complying with obligations to provide or record information for the purpose of contact tracing.
The Act includes provisions for a storage period for entry registration records, an obligation for secure storage of entry registration records, and an obligation to destroy records after the storage period expires, by taking all reasonable steps to ensure that the entry registration information contained in the record cannot be retrieved.
LA: Notice of Motion 15/06/21
LA: 1R 15/06/21, 2R 15/06/21, Passed 15/06/21
LC: 1R 15/06/21, 2R 15/06/21, 17/06/21, Passed 17/06/21
Assent 21/06/21, Act No. 3 of 2021
Commencement: This Act comes into operation as follows -
(a) sections 1 and 2 - on the day on which this Act receives the Royal Assent;
(b) the rest of the Act - on the day after that day.
Return to top